Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, when do you think the r/s will be? It's in two weeks, right? So, if anything, you have two weeks to take the profit and then that's it.
Unless they delayed the r/s, but I don't think they'd delay the r/s, because it benefits them and only them, unless you are short I guess.
For the record, I'm not long and string, I'm long and weak.
The reason I'm not selling is because I've already lost so much, I don't have much more left to lose on AYTU.
Unless my shares go negative after the r/s and I owe AYTU even more!
I would like to agree with you, but AYTU doesn't care about retail or sick people, they just care about profits.
I can smell the hype.
I can't imagine that they would actually manufacture and sell test kits, even with the FDA out of the way.
This is and always has been a share selling scheme.
For the record, I hope you and the other believers are correct, because I really could benefit from at least earning back some of my gigantic losses.
It's really sad to have all of the hype and hysteria, which causes a roller coaster ride of hopes and then shattered dreams.
I doubt the PPS will go anywhere good.
I'm 100% sure the r/s will happen in two weeks.
Maybe a test kit or two will be sold, but the virus will go away with warm weather and therefore, sales will not be sustainable, but we will be stuck with all of the dilution and the r/s.
The market cap will also go down, because the test kit was one of their only half way decent products.
This was a flash in the pan, crash and burn.
The BOD of AYTU is crooked.
No Lupo, I'm not worried about your investment, because you are not way under water like I am, due to having $22 per share, due to the INNV r/s, before it merged into AYTU, which is how I got here.
I am only worried about my investment, because I've been the most screwed of all.
If you had as many losses as I do, then I'd be worried about you as well.
Weldman, it's not a sandbox, it's a shatbox!
You have to understand that even though they have enough capital and the PPS is over $1, it does not matter...
They can do an r/s, which benefits only them and screws over retail and therefore they will do the r/s, to benefit themselves.
Reverse split coming in 2 weeks. You have been warned. Boyd and Damaj won't be left holding the bag. Mass selling into the temporary spikes. Fair market value is -0.16.
No one wants an inaccurate scam test.
Corona virus gone with warmer weather.
Should have invested in Costco 5 years ago.
I have AYTU shares at $22 average PPS, because I was invested in Innovus/INNV and did not sell, before their reverse split.
Then INNV merged with AYTU, that's how I obtained AYTU shares.
Each r/s I suffer through, literally steals my shares and my money.
I never should have gotten into the stock market on my own.
It will be sadly funny, if no test kits are actually sold and this turns out to be a share selling pump and dump as so many have claimed.
I would have preferred if the FDA didn't leave it up to the states to use any willy-nilly test kits and if AYTU had FDA approval.
I'd be surprised to see AYTU get any test kits manufactured, sold and distributed.
Expect more and rapid fire, volcano-diarrhea, dilution tomorrow and after that and after that, day after day, after day, until the reverse split and then...
Much, much, much, more dilution!
Share price tanks to .016 as the fair market value.
LOL, I am in and my average PPS is $22 per share, due to the INNV debacle.
I'm expecting a 100% loss here, which is basically what I've got now.
I need this to go to $22 per share, w/o an r/s, just to break even, due to the INNV debacle, so I'm not impressed.
There's no way they will stop the dilution and reverse split, because they are making a lot of money from scamming retail.
People only change if they feel pain and are punished which will never happen, there won't be any accountability.
AYTU is the perfect scam for Dr.Damaj to flourish in.
You have your decimal point in the wrong place, not $20, but .002, just remember they will reverse split, because they can, not because they have to!
1 trick pony= test kits, just like the 1 trick pony, Fluticare.
The real trick here is the Cayman islands, insider, dilutive selling.
The FDA knows this company is a joke and is aware of Dr.Damaj's schemes.
Opens at .84 and closes at .16, due to insider, Cayman islands dumping.
I told you this scam is getting worse and worse, Dr.Damaj has corrupted it even more!
It's a scam!
Wow, $38 in December 2019 and now after FDA approval, $15 per share.
FDA approval doesn't mean much. It's the sales of the kits that would make a difference, but as DrugDoctor has pointed out, this is a cayman islands scam, the insider selling will keep this down, they don't care about investor value, the only care about enriching insiders.
Dilute! Dilute! Insiders selling! Reverse split, in 2 weeks! FDA will reject test kit! Economy crashing!
Like DrugDoctor has indicated, insiders are selling.
Lol, I'm not telling you to sell and I'm not trying to help you. I'm stating my opinion of what's going to happen and we'll see who's right.
Yes, the hedge fund invested to short, sell, dilute, reverse split and buy back more shares at a lower price, to repeat the process.
Keep this in mind, Armistice Capital-Boyd the activist investor has bailed out of AYTU, for good reason...
This is just another stock dilution/stock selling scam.
The economy and the stock market are collapsing.
Get ready for bankruptcy.
The virus and cure could be over and done with, before test kits are approved.
The FDA never approves small time garbage biotechs, it always approves the big players first.
I need this pos to get to $22 just to break even, after Dr.Damaj F'd Innovus so bad with lies, lack of sales, dumb products, dilution and reverse splits.
I don't see anything good happening here to the AYTU share price.
Even if test kits were approved for the USA, more dilution and shorts will F the share price.
I agree with DrugDoctors negative view on this.
For the record, I agree with Drug Doctor.
This is a share selling, dilution nightmare and it's headed for a reverse split.
No FDA approval and even if it was approved, the money would be in a vaccine/treatment, not in a 90% accurate test kit.
The FDA won't approve this small time companies test kit and if it does get approval, the share price won't increase.
Thank you.
The Evil and corrupted Dr.Damaj does reverse slits like it's a bodily function!
Can you know take down this invalid, post that you pinned at the top?
Obviously, it didn't go to $8 as you stated that it would.
That's good news that it has closed over $1 for 7 days and there for an r/s is not needed.
However, do you know how dirty Dr.Damaj is?
I suspect the Evil Conman Dr.Damaj will r/s this, just to enrich himself and steal our shares and our money...
Dilute, dilute, reverse split, reverse split. Wash, rinse and repeat, over and over again. Meanwhile, Dr.Damaj is getting fatter, richer and happier.
AYTU is being kept down on purpose and will stay down, to allegedly "validate" the need to the reverse split later this month.
Ok, but we need more than $2, we need $8, $10, and $22 for me to break even on this INNV scam and Dr.Damaj's evil reverse splits of darkness.
Funny thing is, there will probably be a reserve split on this in March, even though it's not needed.
Also, the Corona hype will probably be over soon, before even 1 test kit is sold.
The FDA probably won't approve AYTU's test kits.
Test kits don't help much.
A vaccine and/or cure would help more.
I've heard from several source that Bill Gates owns the patent on the Corona virus vaccine, don't ask me how that works, when apparently a vaccine does not exist.
Also, Gilead has a treatment that was reviewed and failed for Ebola, but seems effective for Corona 9.
There was a recent 9 million offer and now a 20 million dilutive offer, keeping the pps down.
Don't forget there will be, yet another reverse split, later this March.
Don't forget, Corona virus testing kits are dumb.
What's best is to have a Corona virus vaccine and short of that, we would benefit more from an effective treatment.
AYTU
AYTUZ
INNV
Will never be a success, only a pump and dump, share selling, dilutive, life style scheme/scam for that EVIL Dr.Damaj.
Dr.Damaj will bring AYTU down to .01 and then do a reverse split.
Wow! What a great company OVIT is...Not!!!
How much did you lose? Remember when you were so RAH! RAH! about Dr.Damaj and you would get so upset when people would told you that it's a share selling scam, and that it will never be profitable and that it will reverse split after reverse split and you defended your pal Dr.Damage.
Who was it? They need to be exposed. Was it Hagen?
Well, my friend Rupert thinks POTN will be a huge success, but I have my doubts.
However, I've never known Rupert to be wrong, especially when it comes to money.
It's too bad POTN is down to 0.173 now.
Lipocine Announces TLANDO(TM) PDUFA Date of August 28, 2020
8:00 AM ET 3/4/20 | Dow Jones
SALT LAKE CITY, March 4, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration ("FDA") acknowledged receipt of the resubmission of TLANDO New Drug Application ("NDA"), the Company's oral testosterone product candidate for testosterone replacement therapy ("TRT") in adult males for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism. TLANDO is part of Lipocine's TRT franchise of development candidates. The FDA has assigned a Prescription Drug User Fee Act ("PDUFA") goal date of August 28, 2020. The NDA incorporates the reanalysis of existing data based on written feedback to address the single remaining deficiency discussed in the Post Action Meeting with the FDA.
"We look forward to continuing to work with the FDA to bring the fixed-dose TLANDO TRT option to patients," said Dr. Mahesh Patel, Chairman, President and Chief Executive Officer of Lipocine.
About Lipocine
Lipocine Inc. is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery technologies. Lipocine's clinical development pipeline includes TLANDO, LPCN 1144, TLANDO XR ("LPCN 1111"), LPCN 1148 and LPCN 1107. TLANDO, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men. Lipocine has resubmitted its NDA to the FDA for TLANDO and has a PDUFA date of August 28, 2020. LPCN 1144, an oral product of bioidentical testosterone, recently completed a proof-of-concept clinical study demonstrating the potential utility in the treatment of pre-cirrhotic NASH. TLANDO XR, a novel oral prodrug of testosterone, originated and is being developed by Lipocine as a next-generation oral testosterone product with potential for once-daily dosing. In a phase 2 clinical evaluation when administered as once daily or twice daily TLANDO XR met the typical primary and secondary end points. LPCN 1148 is an oral prodrug of bioidentical testosterone targeted for the treatment of NASH cirrhosis. LPCN 1107 is potentially the first oral hydroxyprogesterone caproate product candidate, with end of phase 2 meeting completed, indicated for the prevention of recurrent preterm birth and has been granted orphan drug designation by the FDA. For more information, please visit www.lipocine.com.
Forward-Looking Statements
This release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements that are not historical facts regarding Lipocine's product candidates and related clinical trials, the timing of completion of clinical trials, the potential uses and benefits of our product candidates, our product development efforts, and future discussions and potential future actions by the FDA related to TLANDO including the PDUFA date. Investors are cautioned that all such forward-looking statements involve risks and uncertainties, including, without limitation, the risks that the FDA will not approve any of our products, risks related to our products, expected product benefits not being realized, clinical and regulatory expectations and plans not being realized, new regulatory developments and requirements, risks related to the FDA approval process including the receipt of regulatory approvals, the results and timing of clinical trials, patient acceptance of Lipocine's products, the manufacturing and commercialization of Lipocine's products, risk related to on-going litigation and other risks detailed in Lipocine's filings with the SEC, including, without limitation, its Form 10-K and other reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Lipocine assumes no obligation to update or revise publicly any forward-looking statements contained in this release, except as required by law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lipocine-announces-tlando-pdufa-date-of-august-28-2020-301015927.html
SOURCE Lipocine Inc.
/CONTACT: Morgan Brown, Executive Vice President & Chief Financial Officer, (801) 519-4090, mb@lipocine.com; Hans Vitzthum, Phone: (617) 430-7578, hans@lifesciadvisors.com
/Web site: http://www.lipocine.com
> Dow Jones Newswires
March 04, 2020 08:00 ET (13:00 GMT)
Antares Pharma Is Maintained at Strong Buy by Raymond James
7:31 AM ET 3/4/20 | Dow Jones
Ratings actions from Benzinga: https://www.benzinga.com/stock/ATRS/ratings
> Dow Jones Newswires
March 04, 2020 07:31 ET (12:31 GMT)